RhumbLine Advisers
BIVI icon

RhumbLine Advisers’s BioVie BIVI Stock Holding History

RhumbLine Advisers’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7
Closed -$277 – 4211
2024
Q2 		$277 Sell
7
-41
-85% -$1.96K ﹤0.01% 4313
2024
Q1 		$2.54K Buy
48
+1
+2% +$103 ﹤0.01% 4068
2023
Q4 		$5.91K Sell
47
-3
-6% -$901 ﹤0.01% 3949
2023
Q3 		$17K Buy
50
+20
+67% +$7.82K ﹤0.01% 3804
2023
Q2 		$13K Buy
+30
New +$20.2K ﹤0.01% 3885

Other funds holding BIVI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ZIG
Zullo Investment Group Scranton, Pennsylvania $264M AUM 26.77% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
UCMOK
United Capital Management of KS Salina, Kansas $660M AUM 50.85% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

RhumbLine Advisers's BIVI Position: Q3 2024 in Review

RhumbLine Advisers sold out of BioVie (BIVI) in Q3 2024, closing a stake of 7 shares — an estimated $277 sold.

RhumbLine Advisers first reported a position in BIVI in Q2 2023 and held it in 5 quarters. The position peaked at $17K in Q3 2023. 25 funds tracked by Wall St. Rank hold BIVI as of Q3 2024.

  • RhumbLine Advisers reported no remaining BioVie position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 7 BioVie shares in Q3 2024, an estimated $277.
  • RhumbLine Advisers first reported a position in BioVie in Q2 2023 and held it in 5 quarters.
  • RhumbLine Advisers's BioVie position peaked at $17K in Q3 2023.
  • 25 funds tracked by Wall St. Rank held BioVie as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.